- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06529003
TENS Unit To Decrease Pain After Laminaria Insertion
Randomized Controlled Trial: TENS Unit To Decrease Pain After Laminaria Insertion
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
To compare the maximum pain scores reported during the interval between osmotic dilator placement and D&E procedure of patients receiving the standard of care plus sham placebo and those who use an adjunctive Transcutaneous electrical nerve stimulation (TENS) unit in addition to standard of care.
Secondary objectives include comparing pain scores at the time of laminaria insertion, assessing the number and duration of TENS sessions, additional analgesic use, satisfaction with pain management, and patient perception of the ease of use of the TENS unit.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Hawaii
-
Honolulu, Hawaii, United States, 96813
- 1380 Lusitana St. Ste 1004
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients undergoing laminaria insertion for D&E procedure
- Age 18 years or older
- Capability and willingness to send and receive SMS messages by phone and complete web-based surveys
- Capability to read and understand directions for using a TENS unit
- Capability to operate a TENS unit according to provided directions
Exclusion Criteria:
- Inability to complete the informed consent in English
- Exposure to adjunctive pharmacologic cervical preparation (misoprostol or mifepristone) within 48 hours of the D&E procedure
- Contraindication to ibuprofen or bupivacaine
- Contraindication to TENS, including cardiac pacemakers, epilepsy, bleeding disorders, cancer, and concurrent use near transdermal drug delivery systems
- Previous participation in this trial
- Prior use of TENS unit
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo
|
Participants in the placebo group will be given a TENS unit without a battery with similar to the intervention group but will be advised that they may or may not feel a sensation from the electrodes.
All participants will be provided with 15 tabs of ibuprofen 200 mg for outpatient pain control after the procedure.
Participants will be instructed to take 600-800 mg of ibuprofen with food every 6 hours as needed for pain during the time period after laminaria insertion and before dilation and evacuation surgery, which is generally less than 24 hours.
|
|
Active Comparator: TENS unit
|
All participants in this study will receive the standard of care, which includes oral ibuprofen and a paracervical block at the time of laminaria insertion.
Those in the treatment group will receive an adjunctive TENS unit with specific instructions for use in the interval between laminaria insertion and dilation and evacuation the next day.
TENS is a non-invasive, inexpensive, over-the-counter, nonpharmacologic option to relieve pain.
All participants will be provided with 15 tabs of ibuprofen 200 mg for outpatient pain control after the procedure.
Participants will be instructed to take 600-800 mg of ibuprofen with food every 6 hours as needed for pain during the time period after laminaria insertion and before dilation and evacuation surgery, which is generally less than 24 hours.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maximum pain scores
Time Frame: Between osmotic dilator placement and dilation and evacuation procedure (approximately 16-24 hours)
|
To compare the maximum pain scores reported during the interval between osmotic dilator placement and D&E procedure of patients receiving the standard of care plus placebo and those who use an adjunctive transcutaneous electrical nerve stimulation (TENS) unit in addition to standard of care.
Participants will be asked to rank their pain on an 11-point numerical rating scale (0 to 10), with higher numbers indicating worse pain.
|
Between osmotic dilator placement and dilation and evacuation procedure (approximately 16-24 hours)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain at time of laminaria insertion
Time Frame: At time of laminaria insertion
|
Pain scores at the time of laminaria insertion.
Participants will be asked to rank their pain on an 11-point numerical rating scale (0 to 10), with higher numbers indicating worse pain.
|
At time of laminaria insertion
|
|
Number of TENS sessions
Time Frame: Between osmotic dilator placement and dilation and evacuation procedure (approximately 16-24 hours)
|
Number of TENS sessions
|
Between osmotic dilator placement and dilation and evacuation procedure (approximately 16-24 hours)
|
|
Duration of each TENS sessions
Time Frame: Between osmotic dilator placement and dilation and evacuation procedure (approximately 16-24 hours)
|
Duration of each TENS sessions
|
Between osmotic dilator placement and dilation and evacuation procedure (approximately 16-24 hours)
|
|
Satisfaction with pain management
Time Frame: Between osmotic dilator placement and dilation and evacuation procedure (approximately 16-24 hours)
|
Participants will be asked "Overall satisfaction with pain control since the procedure: (0-10 numeric rating scale)" on all five surveys.
A score of 0 indicates "extremely unsatisfied."
A score of 5 indicates "neutral."
A score of 10 indicates "extremely satisfied."
|
Between osmotic dilator placement and dilation and evacuation procedure (approximately 16-24 hours)
|
|
Ease of use
Time Frame: Between osmotic dilator placement and dilation and evacuation procedure (approximately 16-24 hours)
|
Perception of the ease of use of the TENS unit.
At the initial 10-minute mark survey, participants will be asked, "How difficult do you feel it will be to use a TENS unit?
(0-10 numeric rating scale)".
On the final survey (pre-op survey), only participants in the intervention group will be asked, "How difficult was it to use a TENS unit?
(0-10 numeric rating scale)".
A score of 0 indicates "not difficult at all."
A score of 10 indicates "very difficult."
|
Between osmotic dilator placement and dilation and evacuation procedure (approximately 16-24 hours)
|
|
Analgesic use
Time Frame: Between osmotic dilator placement and dilation and evacuation procedure (approximately 16-24 hours)
|
Amount of ibuprofen taken and/or other analgesics
|
Between osmotic dilator placement and dilation and evacuation procedure (approximately 16-24 hours)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Melissa Natavio, MD, MPH, Complex Family Planning, The Queens Medical Center, Department of Obstetrics, Gynecology, and Womens Health
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RA-2024-018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.